Key EventTrading window closure announced for post-results period
Aarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·-0.16%·₹429.05
Key EventBoard reshuffle approved at AGM with new director appointments and reappointments
ImpactLeadership transition may affect governance continuity but maintains operational expertise within the board.Sign up to read impact
Aarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·-0.16%·₹429.05
Key EventAll 16 AGM resolutions passed with requisite majority.
ImpactShareholders overwhelmingly approved all key governance and compensation matters, signaling strong board support.Sign up to read impact
Aarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·-0.16%·₹429.05
Key EventAarti Drugs reported FY26 consolidated revenue of Rs. 2,568 crores, up 7% YoY, with PAT rising 16% to Rs. 312 crores.
ImpactThe company is strategically shifting toward regulated markets and premium APIs, with capex-driven capacity expansion expected to drive margin growth and reduce pricing pressure.Sign up to read impact
Aarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·-0.16%·₹429.05
Key Event41st AGM approved FY2025-26 financials and appointed new directors and managing director.
ImpactShareholders approved key governance changes and financials, signaling leadership continuity.Sign up to read impact
Aarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·+2.2%·₹426.5
No summary available
Sign up to read summaryAarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·+2.2%·₹426.5
Key EventAarti Drugs Limited filed its BRSR report for FY 2025-26 with BSE and NSE on September 2, 2026.
ImpactThe BRSR filing demonstrates Aarti Drugs' structured commitment to ESG compliance, transparency, and sustainable operations, which may enhance long-term stakeholder trust and regulatory alignment.Sign up to read impact
Aarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·+2.2%·₹426.5
No summary available
Sign up to read summaryAarti Drugs Ltd (AARTIDRUGS)
·Next Day Close·+0.26%·₹418.7
Key EventBoard approved Performance Stock Option Plan 2026
Aarti Drugs Limited (AARTIDRUGS)
·Next Day Close·+0.32%·₹421.7
Key EventBoard to approve Performance Stock Option Plan 2026
ImpactShareholders should note insider trading restrictions during the upcoming board meeting week.Sign up to read impact